China / Moderna Steadfast on mRNA IP; Advanced MedTech Buys WIKKON; Menarini/SciClone AMR Deal
A roundup of some of the biggest recent stories from Chinese pharma, including Moderna’s refusal to divulge its mRNA IP, Advanced MedTech’s acquisition of urology leader WIKKON and Menarini’s AMR…